Anglotensin receptor blockers for chronic heart failure and acute myocardial infarctionMCMURRAY, John J. V.Heart (London 1996). 2001, Vol 86, Num 1, pp 97-103, issn 1355-6037Article

Treatment of chronic heart failure : a comparison between the major guidelinesMCMURRAY, John; SWEDBERG, Karl.European heart journal. 2006, Vol 27, Num 15, pp 1773-1777, issn 0195-668X, 5 p.Article

Systolic Heart FailureMCMURRAY, John J. V.The New England journal of medicine. 2010, Vol 362, Num 3, pp 228-238, issn 0028-4793, 11 p.Article

Chronic kidney disease in patients with cardiac disease : A review of evidence-based treatmentMCMURRAY, John J. V.Kidney international. 2005, Vol 68, Num 4, pp 1419-1426, issn 0085-2538, 8 p.Article

New therapeutic options in congestive heart failure. Part IIMCMURRAY, John; PFEFFER, Marc A.Circulation (New York, N.Y.). 2002, Vol 105, Num 18, pp 2223-2228, issn 0009-7322Article

New therapeutic options in congestive heart failure: Part IMCMURRAY, John; PFEFFER, Marc A.Circulation (New York, N.Y.). 2002, Vol 105, Num 17, pp 2099-2106, issn 0009-7322Article

Statins and chronic heart failure: Do we need a large-scale outcome trial?KRUM, Henry; MCMURRAY, John J.Journal of the American College of Cardiology. 2002, Vol 39, Num 10, pp 1567-1573, issn 0735-1097Article

Neurohumoral pathways in heart failure with preserved systolic functionHOGG, Karen; MCMURRAY, John.Progress in cardiovascular diseases. 2005, Vol 47, Num 6, pp 357-366, issn 0033-0620, 10 p.Article

Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart?FISHER, Carol; MACLEAN, Margaret; MORECROFT, Ian et al.Circulation (New York, N.Y.). 2002, Vol 106, Num 3, pp 292-295, issn 0009-7322Article

Valsartan in Acute Myocardial Infarction Trial (VALIANT) : Rationale and designPFEFFER, Marc A; MCMURRAY, John; SELLERS, Mary Ann et al.The American heart journal. 2000, Vol 140, Num 5, pp 727-734, issn 0002-8703Article

Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993CAPEWELL, Simon; BEAGLEHOLE, Robert; SEDDON, Mary et al.Circulation (New York, N.Y.). 2000, Vol 102, Num 13, pp 1511-1516, issn 0009-7322Article

A systematic review of event rates in clinical trials in diabetes mellitus: The importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial designPREISS, David; SATTAR, Naveed; MCMURRAY, John J et al.The American heart journal. 2011, Vol 161, Num 1, pp 210-219, issn 0002-8703, 10 p.Article

Medical management of advanced heart failure = Prise en charge médicale de l'insuffisance cardiaque avancéeMCMURRAY, John-Jv; ROCCHICCIOLI, J-Paul.PROGRESS IN PALLIATIVE CARE. 2008, Vol 16, Num 5-6, pp 229-239, issn 0969-9260, 11 p.Article

Ximelagatran compared with warfarin for the prevention of systemic embolism and stroke An imputed placebo analysisBERRY, Colin; NORRIE, John; MCMURRAY, John J. V et al.Cardiovascular drugs and therapy. 2005, Vol 19, Num 2, pp 149-151, issn 0920-3206, 3 p.Article

Heart failure with preserved left ventricular systolic function: Epidemiology, clinical characteristics, and prognosisHOGG, Karen; SWEDBERG, Karl; MCMURRAY, John et al.Journal of the American College of Cardiology. 2004, Vol 43, Num 3, pp 317-327, issn 0735-1097, 11 p.Article

Pd-C-induced catalytic transfer hydrogenation with triethylsilaneMANDAL, Pijus K; MCMURRAY, John S.Journal of organic chemistry. 2007, Vol 72, Num 17, pp 6599-6601, issn 0022-3263, 3 p.Article

Using measures of disease progression to determine therapeutic effect : A sirens' songGRANGER, Christopher B; MCMURRAY, John J. V.Journal of the American College of Cardiology. 2006, Vol 48, Num 3, pp 434-437, issn 0735-1097, 4 p.Article

Heart failureMCMURRAY, John J. V; PFEFFER, Marca.Lancet (British edition). 2005, Vol 365, Num 9474, pp 1877-1889, issn 0140-6736, 13 p.Article

Treatment of heart failure with spironolactone -trial and tribulationsMCMURRAY, John J. V; O'MEARA, Eileen.The New England journal of medicine. 2004, Vol 351, Num 6, pp 526-528, issn 0028-4793, 3 p.Article

Endothelin receptor antagonists and cardiovascular diseases of agingLOVE, Michael P; MCMURRAY, John J. V.Drugs & aging. 2001, Vol 18, Num 6, pp 425-440, issn 1170-229XArticle

The year in heart failureMCMURRAY, John J. V; PFEFFER, Marc A.Journal of the American College of Cardiology. 2004, Vol 44, Num 12, pp 2398-2405, issn 0735-1097, 8 p.Article

Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitorDAVIE, Andrew P; MCMURRAY, John J. V.British journal of clinical pharmacology. 2002, Vol 53, Num 1, pp 37-42, issn 0306-5251Article

The role of angiotensin II receptor blockers in the management of heart failureMCMURRAY, John J. V.European heart journal supplements. 2005, Vol 7, Num J, pp J10-J14, issn 1520-765XArticle

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance : Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) TrialCALIFF, Robert M; BOOLELL, Mitradev; HAFFNER, Steven M et al.The American heart journal. 2008, Vol 156, Num 4, pp 623-632, issn 0002-8703, 10 p.Article

Prevalence of left-ventricular systolic dysfunction and heart failure in the echocardiographic heart of england screening study: a population based study. CommentaryPETRIE, Mark; MCMURRAY, John; DAVIES, M. K et al.Lancet (British edition). 2001, Vol 358, Num 9280, pp 432-434, issn 0140-6736, 9 p.Article